Company Filing History:
5 out of 5 
1 out of 3,288 
1 out of 1,976 
Years Active: 1987-2001
Title: The Innovations of Rebecca W. Vanderslice
Introduction
Rebecca W. Vanderslice, based in Boulder, Colorado, is a prominent inventor known for her substantial contributions to the field of biotechnology. With a remarkable portfolio of eight patents, her innovative work focuses on polysaccharide polymers and tumor necrosis factor (TNF) inhibitors, showcasing her expertise and dedication to advancing scientific knowledge.
Latest Patents
One of her latest patents is titled "Genetic Control of Acetylation and Pyruvylation of Xanthan Based Polysaccharide Polymers." This patent describes the creation of variant xanthan gums, which include water-soluble polysaccharide polymers made up of repeating pentamer units with a specific ratio of D-glucose, D-mannose, and D-glucuronic acid. The unique configurations and linkages of these moieties contribute to the versatility and functionality of the xanthan-based polymers. Additionally, she holds a patent for a "Tumor Necrosis Factor (TNF) Inhibitor and Method for Obtaining the Same," which discloses the isolation of glycoproteins that act against TNF. This work reveals the amino acid sequences of 30 kDa and 40 kDa TNF inhibitors, highlighting benefits in therapeutic applications.
Career Highlights
Rebecca has had a dynamic career, working with notable companies such as Getty Scientific Development Company and Monsanto Company. Her experience in these organizations has equipped her with the knowledge and skills necessary to develop her patented technologies and has solidified her reputation as an expert in her field.
Collaborations
Throughout her career, Rebecca has collaborated with esteemed colleagues, including Daniel H. Doherty and Donna M. Ferber. These partnerships have further enriched her research and have played a significant role in the success of her innovations.
Conclusion
Rebecca W. Vanderslice exemplifies the spirit of innovation through her extensive patent portfolio and collaborative work in biotechnology. Her dedication to creating novel solutions in the realm of polysaccharide polymers and TNF inhibitors is paving the way for future advancements in medical and biotechnological applications. As her career continues to evolve, her contributions will undoubtedly leave a lasting impact on the industry.